ALISO VIEJO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference. RxSight’s management is scheduled to present on Wednesday, January 15, 2025, at 9:45 a.m. Pacific Time / 12:45 p.m.... Read More

ALISO VIEJO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended September 30, 2024. Key Quarterly Highlights Reported third quarter 2024 revenue of $35.3 million, an increase of 59% compared to the third quarter... Read More

ALISO VIEJO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the third quarter of 2024 after the market close on Thursday, November 7, 2024. The company’s management will discuss the results during a conference call beginning at... Read More

ALISO VIEJO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced its plans to participate in two upcoming healthcare conferences in September. Morgan Stanley 22 nd Annual Global Healthcare Conference - Fireside Chat: Wednesday, September 4, 2024, at 9:15 a.m. ET... Read More

ALISO VIEJO, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended June 30, 2024. Key Quarterly Highlights Reported second quarter 2024 revenue of $34.9 million, an increase of 68% compared to the second quarter of 2023,... Read More

ALISO VIEJO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the second quarter of 2024 after the market close on Monday, August 5, 2024. The company’s management will discuss the results during a conference call... Read More

ALISO VIEJO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Truist Securities MedTech Conference. RxSight’s management is scheduled to participate in a fireside chat on Tuesday, June 18, 2024, at 12:05 p.m. Pacific Time / 3:05 p.m.... Read More

ALISO VIEJO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. (Nasdaq: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it has closed its underwritten public offering of 2,053,571 shares of its common stock, at a price to the public of $56.00 per share, which includes the full exercise by the underwriters of... Read More

ALISO VIEJO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, announced today that it has priced its underwritten public offering. RxSight expects to sell 1,785,714 shares of its common stock at a price to the public of $56.00 per share. RxSight has granted the... Read More

ALISO VIEJO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. , (Nasdaq: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, announced today that it intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering. In addition, RxSight expects to grant the... Read More

ALISO VIEJO, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., (NASDAQ: RXST) an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended March 31, 2024. Key Quarterly Highlights Reported first quarter 2024 revenue of $29.5 million, an increase of 69% compared to the first quarter of 2023,... Read More

ALISO VIEJO, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare Conference. RxSight’s management is scheduled to present on Wednesday, May 15, 2024, at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time.... Read More

ALISO VIEJO, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the first quarter of 2024 after the market close on Monday, May 6, 2024. The company’s management will discuss the results during a conference call... Read More

ALISO VIEJO, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc ., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced the commercial launch of its newest Light Adjustable Lens, the LAL+. The company now offers two lenses in the Light Adjustable Lens platform: the LAL ® and the Light Adjustable Lens+ ™ (LAL+).... Read More

ALISO VIEJO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference. RxSight’s management is scheduled to participate in a fireside chat on Wednesday, April 10, 2024, at 12:45... Read More

ALISO VIEJO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming 34th Annual Oppenheimer Healthcare Conference. RxSight’s management is scheduled to participate in a fireside chat on Wednesday, March 13, 2024, at 8:20 a.m.... Read More

ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months and full year ended December 31, 2023. Key Quarterly and Full Year Highlights Recognized fourth quarter 2023 revenue of $28.6 million, an increase of 78% compared to the... Read More

ALISO VIEJO, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the fourth quarter and full year 2023 after the market close on Wednesday, February 28, 2024. The company’s management will discuss the results during a... Read More

ALISO VIEJO, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced certain preliminary unaudited financial and operational results for the fourth quarter and full-year 2023 and provided full-year 2024 guidance. Preliminary Unaudited Fourth Quarter and Full-year 2023 Results... Read More

ALISO VIEJO, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference. RxSight’s management is scheduled to present on Wednesday, January 10, 2024, at 3:00 p.m. Pacific Time / 6:00 p.m. Eastern Time.... Read More

ALISO VIEJO, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three and nine months ended September 30, 2023. Key Quarterly Highlights Reported third quarter 2023 revenue of $22.2 million, an increase of 76% compared to the third... Read More

ALISO VIEJO, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- November 2, 2023 – RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced educational opportunities and product updates at the American Academy of Ophthalmology (AAO) Annual Meeting on November 3 – 6 in San Francisco. These include three scientific poster... Read More

ALISO VIEJO, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the third quarter 2023 after the market close on Thursday, November 9, 2023. The company’s management will discuss the results during a conference call... Read More

ALISO VIEJO, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Wells Fargo Healthcare Conference. RxSight’s management is scheduled to participate in a fireside chat on Wednesday, September 6, 2023, at 1:30 p.m. Pacific Time / 4:30 p.m.... Read More

ALISO VIEJO, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three and six months ended June 30, 2023. Key Quarterly Highlights Reported second quarter 2023 revenue of $20.8 million, an increase of 83% compared to the second quarter of 2022,... Read More

ALISO VIEJO, Calif., July 25, 2023 (GLOBE NEWSWIRE) – RxSight, Inc. (NASDAQ: RXST) , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the second quarter 2023 after the market close on Monday, August 7, 2023. The company’s management will discuss the results during a conference call... Read More

ALISO VIEJO, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc. , (NASDAQ: RXST) an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended March 31, 2023. Key Quarterly Highlights Reported first quarter 2023 revenue of $17.5 million, an increase of 96% compared to the first quarter of 2022,... Read More

ALISO VIEJO, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare Conference. RxSight’s management is scheduled to present on Wednesday, May 10, 2023, at 3:55 p.m. Pacific Time / 6:55 p.m.... Read More

ALISO VIEJO, Calif., April 25, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the first quarter 2023 after the market close on Tuesday, May 9, 2023. The company’s management will discuss the results during a conference call... Read More

ALISO VIEJO, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that its Light Adjustable Lens™ system will be the subject of multiple surgeon presentations at the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) being held... Read More

ALISO VIEJO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc. , an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Needham Healthcare Conference. RxSight’s management is scheduled to participate in a fireside chat on Wednesday, April 19, 2023, at 11:15 a.m. Pacific Time... Read More

ALISO VIEJO, Calif., March 06, 2023 (GLOBE NEWSWIRE) – RxSight, Inc. , (NASDAQ: RXST) an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months and full year ended December 31, 2022. Key Quarterly and Full Year Highlights Recognized fourth quarter 2022 revenue of $16.1 million, an increase of 91%... Read More

ALISO VIEJO, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Oppenheimer Healthcare Conference. RxSight’s management is scheduled to present on Monday, March 13, 2023, at 7:00 a.m. Pacific Time / 10:00 a.m. Eastern Time. Interested... Read More

ALISO VIEJO, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high quality customized vision to patients following cataract surgery, today announced that it will report financial results for the fourth quarter and fiscal year 2022 after the market close on Monday, March 6, 2023. The company’s management will discuss the results during a... Read More

ALISO VIEJO, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc. (“RxSight ® ”), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that, in connection with its previously announced public offering of common stock (the “Offering”), the underwriters exercised in full their option to purchase an additional 600,000 shares of RxSight’s common stock... Read More

ALISO VIEJO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, announced today that it intends to offer and sell, subject to market and other conditions, $40.0 million of shares of its common stock in an underwritten public offering. In addition, RxSight expects to grant the underwriters a... Read More

ALISO VIEJO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc. (“RxSight”), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, announced today that it has priced its underwritten public offering. RxSight expects to sell 4,000,000 shares of its common stock at a price to the public of $12.50 per share. RxSight has granted the underwriter a... Read More

ALISO VIEJO, Calif., Jan. 08, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc. , an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced certain preliminary unaudited financial and operational results for the fourth quarter and full-year 2022. Preliminary Unaudited Results Preliminary unaudited fourth quarter 2022 revenue is expected to be... Read More

ALISO VIEJO, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc. , an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference. RxSight’s management is scheduled to present on Wednesday, January 11, 2023, at 11:15 a.m. Pacific Time / 2:15 p.m. Eastern Time. Interested... Read More